User account

Providing practical opinion to support best practice for busy healthcare professionals

European Medicines Agency Recommends Granting a Marketing Authorisation for Biosimilar Filgrastim European Medicines Agency Recommends Granting a Marketing Authorisation for Ibrutinib European Medicines Agency Recommends Extension of Indications for Denosumab European Medicines Agency Recommends Approval of Idelalisib ESMO Press Release: Is Europe Putting Cancer Research at Risk? FDA Approves PI3K Inhibitor, Idelalisib for Treatment of Relapsed CLL, Follicular Lymphoma and SLL MED12 Somatic Mutations in Breast Fibroadenoma Acquired Resistance to Tyrosine Kinase Inhibitors in Solid Tumours Prostate Cancer in Young Men CLARINET Study in Metastatic Enteropancreatic NETs Published in the New England Journal of Medicine

User account